Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes

Amanda B. Muir*, Elizabeth T. Jensen, Joshua B. Wechsler, Paul Menard-Katcher, Gary W. Falk, Seema S. Aceves, Glenn T. Furuta, Evan S. Dellon, Mark E. Rothenberg, Jonathan M. Spergel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)2434-2436
Number of pages3
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume7
Issue number7
DOIs
StatePublished - Sep 1 2019

Funding

This study was funded by the Consortium for Eosinophilic Gastrointestinal Disease Research (CEGIR) (grant no. U54 AI117804) as part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), and is cofunded by National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, and NCATS. CEGIR is also supported by patient advocacy groups including the American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Disease, and Eosinophilic Family Coalition.

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this